TislelizumabCytokine release syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2041卷 / 1期

关键词：

D O I：

10.1007/s40278-025-74774-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：385 / 385

相关论文

共 50 条

[31] AlemtuzumabCytokine release syndrome: case report
Reactions Weekly, 2015, 1569 (1) : 19 - 19
[32] TisagenlecleucelCytokine release syndrome: case report
Reactions Weekly, 2025, 2049 (1) : 337 - 337
[33] PembrolizumabCytokine release syndrome: case report
Reactions Weekly, 2024, 2023 (1) : 341 - 341
[34] PembrolizumabCytokine release syndrome: case report
Reactions Weekly, 2019, 1744 (1) : 219 - 219
[35] RituximabCytokine release syndrome: case report
Reactions Weekly, 2021, 1884 (1) : 378 - 378
[36] AlemtuzumabCytokinese release syndrome: case report
Reactions Weekly, 2021, 1836 (1) : 35 - 35
[37] MethylprednisoloneCytokine release syndrome: case report
Reactions Weekly, 2024, 2022 (1) : 171 - 171
[38] PembrolizumabCytokine release syndrome (First report): case report
Reactions Weekly, 2017, 1650 (1) : 224 - 224
[39] Axicabtagene ciloleucelCytokine release syndrome: case report
Reactions Weekly, 2019, 1740 (1) : 54 - 54
[40] TisagenlecleucelCytokine release syndrome and neurotoxicity: case report
Reactions Weekly, 2022, 1912 (1) : 420 - 420

← 1 2 3 4 5 →